Embla Medical hf. Share Price
Equities
EMBLA
IS0000000040
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.60 DKK | +0.99% |
|
+2.00% | -5.85% |
| 03/02 | Embla Medical hf., Q4 2025 Earnings Call, Feb 03, 2026 | |
| 03/02 | Embla Medical hf. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 | CI |
| Capitalization | 207.82Cr 1.31TCr 175.11Cr 159.72Cr 152.48Cr 283.05Cr 19TCr 294.09Cr 1.86TCr 737.47Cr 9.09TCr 779.37Cr 763.35Cr 32TCr | P/E ratio 2026 * |
21.3x | P/E ratio 2027 * | 18x |
|---|---|---|---|---|---|
| Enterprise value | 246.68Cr 1.55TCr 207.85Cr 189.58Cr 180.99Cr 335.98Cr 22TCr 349.08Cr 2.21TCr 875.37Cr 11TCr 925.1Cr 906.08Cr 38TCr | EV / Sales 2026 * |
2.41x | EV / Sales 2027 * | 2.18x |
| Free-Float |
48.44% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Embla Medical hf.
| 1 day | +0.99% | ||
| 1 week | +2.00% | ||
| Current month | -3.47% | ||
| 1 month | -5.26% | ||
| 3 months | -10.26% | ||
| Current year | -5.85% |
| 1 week | 30 | 31.7 | |
| 1 month | 29.3 | 33.1 | |
| Current year | 29.3 | 33.1 | |
| 1 year | 25 | 37.9 | |
| 3 years | 25 | 38 | |
| 5 years | 25 | 49.85 | |
| 10 years | 21.74 | 57.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sveinn Sölvason
CEO | Chief Executive Officer | 48 | 01/04/2022 |
| Director of Finance/CFO | 60 | 01/09/2022 | |
Lukas Märklin
COO | Chief Operating Officer | 52 | 15/06/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Niels Jacobsen
CHM | Chairman | 68 | 01/01/2006 |
Svafa Grönfeldt
BRD | Director/Board Member | 61 | 01/02/2008 |
| Director/Board Member | 57 | 01/01/2009 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.99% | +2.00% | -8.93% | -12.07% | 207.82Cr | ||
| -1.12% | -2.21% | -23.46% | -24.32% | 2.02TCr | ||
| -1.49% | -3.84% | -34.60% | -13.69% | 1.54TCr | ||
| +1.17% | -20.35% | -26.69% | -11.04% | 920.69Cr | ||
| +2.32% | -5.67% | - | - | 435.92Cr | ||
| -0.75% | -1.26% | -39.61% | -53.02% | 166.57Cr | ||
| -1.05% | +1.69% | +29.23% | -37.89% | 165.91Cr | ||
| 0.00% | -0.85% | +51.55% | +78.35% | 70Cr | ||
| -1.82% | +5.11% | +20.27% | - | 37Cr | ||
| +2.08% | -0.64% | -42.81% | +93.96% | 32Cr | ||
| Average | +0.03% | -2.70% | -8.34% | +2.53% | 559.19Cr | |
| Weighted average by Cap. | -0.45% | -5.51% | -24.38% | -17.47% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 102.51Cr 645.31Cr 86Cr 79Cr 75Cr 139.61Cr 9.28TCr 145.06Cr 916.31Cr 363.76Cr 4.48TCr 384.42Cr 376.52Cr 16TCr | 111.01Cr 698.84Cr 94Cr 85Cr 81Cr 151.19Cr 10TCr 157.09Cr 992.32Cr 393.93Cr 4.86TCr 416.31Cr 407.75Cr 17TCr |
| Net income | 9.69Cr 61Cr 8.16Cr 7.45Cr 7.11Cr 13Cr 877.65Cr 14Cr 87Cr 34Cr 423.83Cr 36Cr 36Cr 1.48TCr | 11Cr 71Cr 9.56Cr 8.72Cr 8.33Cr 15Cr 1.03TCr 16Cr 101.46Cr 40Cr 496.44Cr 43Cr 42Cr 1.74TCr |
| Net Debt | 39Cr 244.63Cr 33Cr 30Cr 29Cr 53Cr 3.52TCr 55Cr 347.37Cr 137.9Cr 1.7TCr 145.73Cr 142.74Cr 5.94TCr | 34Cr 215.4Cr 29Cr 26Cr 25Cr 47Cr 3.1TCr 48Cr 305.86Cr 121.42Cr 1.5TCr 128.32Cr 125.68Cr 5.23TCr |
Employees
4,195
Calendar
10/03
- Annual General Meeting
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/26/13 | 30.60 kr | +0.99% | 11,402 |
| 12/26/12 | 30.30 kr | +0.66% | 12,999 |
| 11/26/11 | 30.10 kr | -3.53% | 29,025 |
| 10/26/10 | 31.20 kr | +0.32% | 34,003 |
| 09/26/09 | 31.10 kr | +3.67% | 22,826 |
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
30.60DKK
Average target price
37.40DKK
Spread / Average Target
+22.22%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- EMBLA Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition

















